234 related articles for article (PubMed ID: 15178918)
21. Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves' disease and a neutrophilic dermatosis.
Miller RM; Darben TA; Nedwich J; Savige J
Br J Dermatol; 1999 Nov; 141(5):943-4. PubMed ID: 10583195
[No Abstract] [Full Text] [Related]
22. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital.
Visavachaipan N; Ong-Ajyooth L; Chanchairujuira T; Parichatikanond P; Choensuchon B
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S139-46. PubMed ID: 20364568
[TBL] [Abstract][Full Text] [Related]
23. Concurrent Takayasu's arteritis and antineutrophil cytoplasmic antibody-related glomerulonephritis related to use of propylthiouracil.
Baker-LePain JC; Farmer-Boatwright MK; Dooley MA
J Rheumatol; 2009 Jul; 36(7):1552-4. PubMed ID: 19567638
[No Abstract] [Full Text] [Related]
24. [Propylthiouracil-induced multispecific antineutrophil cytoplasmic antibodies].
Servonnet A; Garcia-Hejl C; Banal F; Ramirez J; Fontan E
Rev Med Interne; 2010 Oct; 31(10):e9-e10. PubMed ID: 20605662
[TBL] [Abstract][Full Text] [Related]
25. Propylthiouracil-induced rapidly progressive glomerulonephritis associated with antineutrophil cytoplasmic autoantibodies.
Kudoh Y; Kuroda S; Shimamoto K; Iimura O
Clin Nephrol; 1997 Jul; 48(1):41-3. PubMed ID: 9247777
[TBL] [Abstract][Full Text] [Related]
26. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil.
Winters MJ; Hurley RM; Lirenman DS
Pediatr Nephrol; 2002 Apr; 17(4):257-60. PubMed ID: 11956877
[TBL] [Abstract][Full Text] [Related]
27. Propylthiouracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease.
Panamonta O; Sumethkul V; Radinahmed P; Laopaiboon M; Kirdpon W
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):539-43. PubMed ID: 18717240
[TBL] [Abstract][Full Text] [Related]
28. Lupus nephritis with positive myeloperoxidase/proteinase 3-antineutrophil cytoplasmic autoantibody that developed after 17 years of propylthiouracil therapy.
Taguchi T; Nakayama S; Fujimoto S; Terada Y
Endocrine; 2014 Jun; 46(2):357-9. PubMed ID: 24272591
[No Abstract] [Full Text] [Related]
29. Cryoglobulins and multispecific antineutrophil cytoplasmic antibodies in propylthiouracil-induced necrotizing cutaneous vasculitis--a new association.
Zivanovic D; Dobrosavljevic D; Nikolic M; Bonaci-Nikolic B
Eur J Dermatol; 2012; 22(5):707-9. PubMed ID: 22858991
[No Abstract] [Full Text] [Related]
30. [Antineutrophil cytoplasmic antibody associated vasculitis: an uncommon side effect of propylthiouracil].
Pasquet F; Pavic M; Mounier C; Karkowski L; Colle B
Rev Med Interne; 2009 Oct; 30(10):882-5. PubMed ID: 19740576
[TBL] [Abstract][Full Text] [Related]
31. Clinical importance of antineutrophil cytoplasmic antibody positivity during propylthiouracil treatment.
Yazisiz V; Ongüt G; Terzioğlu E; Karayalçin U
Int J Clin Pract; 2010 Jan; 64(1):19-24. PubMed ID: 18284438
[TBL] [Abstract][Full Text] [Related]
32. [MPO-ANCA related vasculitis with pulmonary hemorrhage during propylthiouracil (PTU) therapy].
Fujii A; Arimura Y; Minoshima S; Kobayashi M; Yoshihara K; Tanaka U; Nakabayashi K; Kitamoto K; Nagasawa T; Takahashi H
Ryumachi; 1997 Dec; 37(6):788-93. PubMed ID: 9492566
[TBL] [Abstract][Full Text] [Related]
33. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves' disease.
Miller RM; Savige J; Nassis L; Cominos BI
Australas J Dermatol; 1998 May; 39(2):96-9. PubMed ID: 9611379
[TBL] [Abstract][Full Text] [Related]
34. Progressive bilateral sensorineural hearing loss induced by an antithyroid drug.
Sano M; Kitahara N; Kunikata R
ORL J Otorhinolaryngol Relat Spec; 2004; 66(5):281-5. PubMed ID: 15583443
[TBL] [Abstract][Full Text] [Related]
35. [Neutrophilic dermatosis associated with anti-neutrophilic cytoplasmic antibodies (ANCA) after benzylthiouracil therapy].
Frigui M; Masmoudi A; Kaddour N; Jlidi R; Turki H; Bahloul Z
Ann Dermatol Venereol; 2009 May; 136(5):422-6. PubMed ID: 19442798
[TBL] [Abstract][Full Text] [Related]
36. [A case of membranous nephropathy with ANCA-associated necrotizing glomerulonephritis during oral administration of PTU for Graves' disease].
Fujii T; Kawamata T; Ueda S; Akikusa B; Hasegawa S; Tsukahara T; Iesato K; Ogawa M; Saisho H
Nihon Jinzo Gakkai Shi; 2003; 45(8):771-7. PubMed ID: 14737995
[TBL] [Abstract][Full Text] [Related]
37. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.
Tanemoto M; Miyakawa H; Hanai J; Yago M; Kitaoka M; Uchida S
Am J Kidney Dis; 1995 Nov; 26(5):774-80. PubMed ID: 7485130
[TBL] [Abstract][Full Text] [Related]
38. Antineutrophil cytoplasmic antibody-positive cutaneous leukocytoclastic vasculitis associated with propylthiouracil therapy.
Sheen YS; Chu CY; Yu HS
Arch Dermatol; 2006 Jul; 142(7):879-80. PubMed ID: 16847204
[No Abstract] [Full Text] [Related]
39. Granulomatosis with Polyangiitis Presenting with Pyoderma Gangrenosum-Like Ulceration and Negative Cytoplasmic Antineutrophilic Cytoplasmic Antibodies in a Child.
Kass A; Fagan JD; Long P
Pediatr Dermatol; 2017 Sep; 34(5):e231-e234. PubMed ID: 28884919
[TBL] [Abstract][Full Text] [Related]
40. Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves' patients treated with propylthiouracil.
Cin MO; Gursoy A; Morris Y; Aydintug OT; Kamel N; Gullu S
Int J Clin Pract; 2009 Feb; 63(2):299-302. PubMed ID: 19196368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
